Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 5 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//PSYCHOLOGY, EXPERIMENTAL | 1830502 |
| 154 | 3 | NEUROSCIENCES//HYPERALGESIA//OPIOID RECEPTORS | 64165 |
| 1161 | 2 | NOCICEPTIN//ORPHANIN FQ//NOCICEPTIN ORPHANIN FQ | 9812 |
| 36014 | 1 | AGONIST ANTAGONIST DISCRIMINATION//THERMODYNAMIC DISCRIMINATION//8 OH DPAT WAY 100135 | 104 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | AGONIST ANTAGONIST DISCRIMINATION | authKW | 681858 | 3% | 75% | 3 |
| 2 | THERMODYNAMIC DISCRIMINATION | authKW | 404064 | 2% | 67% | 2 |
| 3 | 8 OH DPAT WAY 100135 | authKW | 303049 | 1% | 100% | 1 |
| 4 | AGONIST AND ANTAGONIST DISCRIMINATION | authKW | 303049 | 1% | 100% | 1 |
| 5 | ANTAGONIST BINDING ENTHALPIES | authKW | 303049 | 1% | 100% | 1 |
| 6 | ATRIAL BEATS | authKW | 303049 | 1% | 100% | 1 |
| 7 | BETA ADRENOCEPTOR AGONIST INTERACTION | authKW | 303049 | 1% | 100% | 1 |
| 8 | CCK2S RECEPTORS | authKW | 303049 | 1% | 100% | 1 |
| 9 | CHAOTROPIC EFFECTS OF THIOCYANATE | authKW | 303049 | 1% | 100% | 1 |
| 10 | CRUDE POLYPHENOL | authKW | 303049 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 1042 | 58% | 0% | 60 |
| 2 | Social Sciences, Interdisciplinary | 78 | 5% | 0% | 5 |
| 3 | Biochemistry & Molecular Biology | 36 | 19% | 0% | 20 |
| 4 | Chemistry, Medicinal | 30 | 6% | 0% | 6 |
| 5 | Computer Science, Interdisciplinary Applications | 15 | 4% | 0% | 4 |
| 6 | Medicine, Research & Experimental | 10 | 5% | 0% | 5 |
| 7 | Crystallography | 7 | 3% | 0% | 3 |
| 8 | Cell Biology | 5 | 6% | 0% | 6 |
| 9 | Toxicology | 5 | 3% | 0% | 3 |
| 10 | Integrative & Complementary Medicine | 5 | 1% | 0% | 1 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | MESA INT VENTU | 303049 | 1% | 100% | 1 |
| 2 | PHARMACEUT CHEM CO DD | 303049 | 1% | 100% | 1 |
| 3 | CHAIR PHARMACOL MED | 101015 | 1% | 33% | 1 |
| 4 | CLIN EXPT MEDPHARMACOL UNIT | 75761 | 1% | 25% | 1 |
| 5 | MORPHOL HISTOL | 75759 | 2% | 13% | 2 |
| 6 | NAZL ECCELLENZA SVILUPPO METODOL INNOVAT STUD | 50506 | 1% | 17% | 1 |
| 7 | MED CLIN SPERIMENTALE | 17825 | 1% | 6% | 1 |
| 8 | STRUCT DIFFRACTOMETRY | 15151 | 1% | 5% | 1 |
| 9 | INTERDISCIPLINARY STUDY INFLAMMAT | 10098 | 2% | 2% | 2 |
| 10 | PHARMACOL UNIT | 5989 | 5% | 0% | 5 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CURRENT CONTENTS/CLINICAL MEDICINE | 5661 | 2% | 1% | 2 |
| 2 | BIOCHEMICAL PHARMACOLOGY | 3664 | 14% | 0% | 15 |
| 3 | CURRENT CONTENTS/LIFE SCIENCES | 1970 | 2% | 0% | 2 |
| 4 | BIOCHEMISTRY-MOSCOW | 1484 | 6% | 0% | 6 |
| 5 | JOURNAL OF MOLECULAR GRAPHICS | 1376 | 1% | 0% | 1 |
| 6 | EUROPEAN JOURNAL OF PHARMACOLOGY | 1289 | 11% | 0% | 11 |
| 7 | VOPROSY MEDITSINSKOI KHIMII | 1176 | 3% | 0% | 3 |
| 8 | JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH | 1137 | 1% | 0% | 1 |
| 9 | EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1130 | 2% | 0% | 2 |
| 10 | IZVESTIYA AKADEMII NAUK SSSR SERIYA BIOLOGICHESKAYA | 999 | 2% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |